-
Mashup Score: 0The Weekly Roundup: May 12-17 - 9 hour(s) ago
In case you missed it, this week we had news about roflumilast foam’s efficacy in diverse hair types of seborrheic dermatitis, Lindus Health’s new partnership to evaluate a benzoyl peroxide alternative, sonelokimab advancing to phase 3 for HS, and more.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0
Scassellati Sforzolini discusses the significance of Galderma’s nemolizumab receiving 4 additional filing acceptances for prurigo nodularis and atopic dermatitis.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0Photographer Behind AbbVie's Clearly Me Campaign for Amplifying Voices of Psoriasis Speaks to Advocacy, Awareness - 13 hour(s) ago
Clearly Me uses portraiture to spotlight the journeys of psoriasis patients Katie Lowes, DaQuane Cherry, Ayesha Patrick, and Joanna “JoJo” Pomerantz.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 1Dermatophytoma: A Diagnosis That You Do Not Want to Miss - 15 hour(s) ago
It is important dermatologists learn to recognize the clinical findings of dermatophytomas and distinguish them from other onychomycosis subtypes because the recommended treatments differ.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 1QUIZ RECAP: Advanced Skin Cancer Awareness - 17 hour(s) ago
Earlier this week, we shared our second Skin Cancer Awareness Month quiz. Review the answers and your responses below.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 5
Researchers reviewed research into the medical and toxicological viewpoints of tattooing the skin from the past decade.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 2Exploring the Relationship Between Oligodontia and Hair Abnormalities: A Study Overview - 3 day(s) ago
A recent study spotlights an opportunity for interdisciplinary collaboration between dermatologists and orthodontists.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 3Understanding Drug Interactions in Systemic Treatment: Impact on Atopic Dermatitis Symptoms - 3 day(s) ago
Dr Alexandra Golant discusses managing multiple conditions in a 17-year-old African American waitress, highlighting the complexities of treating moderate-to-severe atopic dermatitis alongside severe acne and oral contraceptives. She also addresses potential drug interactions, focusing on the safety of dupilumab in systemic treatment.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 3MoonLake’s Sonelokimab Trial for HS Advances to Phase 3 - 3 day(s) ago
VELA is the first phase 3 hidradenitis suppurativa trial to evaluate HiSCR75 as the primary end point.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 0
Bristol Myers Squibb announced 70% of patients maintained significant improvement after 4 years with no new safety concerns.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
Our roundup of Dermatology Times news from the past week includes roflumilast foam's efficacy in diverse hair types of seborrheic dermatitis, Lindus Health's new partnership to evaluate a benzoyl peroxide alternative, and more. https://t.co/FbIwaFuIOT